Back to search
FDAFDA · Food and drugs·Recall number Z-1586-2022

a. ABX PENTRA CREATININE 120CP JAFFE 120/130. Ref: A11A01933. b. Reagent General Chemistry Creatinine Model Number: 1220001933

Published August 31, 2022 · Recall initiated: May 25, 2022

Summary

FDA records medical device Class II recall Z-1586-2022, published August 31, 2022 and initiated May 25, 2022. Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office; Status: Ongoing; Reported quantity: a. 28 b. 22; Lot: GTIN: 03610230005736 Lots Distributed: 5/30/2021 - 9/8/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mckesson Medical-Surgical Inc. Corporate Office
Distributor
US Nationwide
Lot
GTIN: 03610230005736 Lots Distributed: 5/30/2021 - 9/8/2021
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was a. ABX PENTRA CREATININE 120CP JAFFE 120/130. Ref: A11A01933. b. Reagent General Chemistry Creatinine Model Number: 1220001933 recalled?

Yes. FDA published recall Z-1586-2022 on August 31, 2022. Reported hazard: Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit